Company Filing History:
Years Active: 2014-2018
Title: Jordan J Toutounchian: Innovator in Retinal Health
Introduction
Jordan J Toutounchian is a notable inventor based in Memphis, TN (US). He has made significant contributions to the field of retinal health through his innovative research and patented methods. With a total of 4 patents, his work focuses on improving the viability of retinal endothelial cells and developing treatments for various retinal conditions.
Latest Patents
One of his latest patents is titled "Method for regulating retinal endothelial cell viability." This patent provides a method for regulating retinal endothelial cell viability in mammals by administering a therapeutically effective amount of a quinic acid analog. This method may be applied to prevent, treat, or cure pathological conditions of retinal endothelial cells associated with radiation retinopathy, diabetic retinopathy, and chemotherapy for retinoblastoma. Another significant patent is "Inhibitors of paxillin function and related compositions and methods." This disclosure relates to small molecule inhibitors of paxillin and paxillin binding, along with related compositions and methods of treatment.
Career Highlights
Jordan J Toutounchian is affiliated with the University of Tennessee Research Foundation, where he conducts his research and develops his innovative solutions. His work has garnered attention for its potential impact on treating serious retinal conditions.
Collaborations
He has collaborated with notable colleagues, including Charles Ryan Yates and Duane Douglas Miller, to advance his research and patent applications.
Conclusion
Jordan J Toutounchian stands out as an influential inventor in the field of retinal health, with a focus on innovative methods that could significantly improve patient outcomes. His contributions through patents reflect his commitment to advancing medical science and technology.